BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20615576)

  • 1. Local failure after complete resection of N0-1 non-small cell lung cancer.
    Saynak M; Veeramachaneni NK; Hubbs JL; Nam J; Qaqish BF; Bailey JE; Chung W; Marks LB
    Lung Cancer; 2011 Feb; 71(2):156-65. PubMed ID: 20615576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients.
    Kelsey CR; Marks LB; Hollis D; Hubbs JL; Ready NE; D'Amico TA; Boyd JA
    Cancer; 2009 Nov; 115(22):5218-27. PubMed ID: 19672942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local failure in resected N1 lung cancer: implications for adjuvant therapy.
    Higgins KA; Chino JP; Berry M; Ready N; Boyd J; Yoo DS; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):727-33. PubMed ID: 22208965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Persistent Problem of Local/Regional Failure After Surgical Intervention for Early-Stage Lung Cancer.
    Judy GD; Kaidar-Person O; Deal A; Wang Y; Migliardi A; Long J; Haithcock B; Marks LB
    Ann Thorac Surg; 2018 Aug; 106(2):382-389. PubMed ID: 29723532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
    Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
    Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
    Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):87-93. PubMed ID: 15632829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.
    Grills IS; Mangona VS; Welsh R; Chmielewski G; McInerney E; Martin S; Wloch J; Ye H; Kestin LL
    J Clin Oncol; 2010 Feb; 28(6):928-35. PubMed ID: 20065181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction therapy followed by surgery for T3-T4/N0 non-small cell lung cancer: long-term results.
    Lococo F; Cesario A; Margaritora S; Dall'Armi V; Nachira D; Cusumano G; Meacci E; Granone P
    Ann Thorac Surg; 2012 May; 93(5):1633-40. PubMed ID: 22480394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative (125)I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer.
    Voynov G; Heron DE; Lin CJ; Burton S; Chen A; Quinn A; Santos R; Colonias A; Landreneau RJ
    Brachytherapy; 2005; 4(4):278-85. PubMed ID: 16344258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
    El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage IB nonsmall cell lung cancers: are they all the same?
    Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
    Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
    Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
    Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure rates and patterns of recurrence in patients with resected N1 non-small-cell lung cancer.
    Varlotto JM; Medford-Davis LN; Recht A; Flickinger JC; Schaefer E; DeCamp MM
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):353-9. PubMed ID: 20732754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
    Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
    Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer.
    Higgins K; Chino JP; Marks LB; Ready N; D'Amico TA; Clough RW; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1462-7. PubMed ID: 19467798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.